Uji klinis Flu di Illinois
7 studi untuk Flu mencari peserta di lokasi di Illinois.
Kota di Illinois
Teks studi resmi (Bahasa Inggris)
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
- Ann Robert H. Lurie Children's Hospital of Chicago, Chicago
Menerima pesertaFase 2
Usia 3 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05947071A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
- GSK Investigational Site, Chicago
- GSK Investigational Site, Morton
- GSK Investigational Site, Peoria
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07805707Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
- AMR Chicago- Site Number : 8400005, Oak Brook
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07779408Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Evanston
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05624450Dime La VerDAD: Verify, Debunk, and Disseminate
- University of Chicago, Chicago
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06417762The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
- Ann and Robert Lurie's Children Hospital of Chicago, Chicago
Menerima pesertaSukarelawan sehat diterima
6 Months – 99 Years · Semua jenis kelamin · Diperbarui 8 Apr 2026 · NCT05832307Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- University of Illinois Health, Chicago
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jul 2024 · NCT02735707Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.